首页 | 本学科首页   官方微博 | 高级检索  
检索        

长链非编码RNA SPRY4-IT1在食管鳞癌中的表达及对细胞生长的影响
引用本文:谢海伟,陈仿军,朱斌,曹刚,金磊,周国志,吕进,曹秀峰.长链非编码RNA SPRY4-IT1在食管鳞癌中的表达及对细胞生长的影响[J].中国肿瘤临床,2013,40(17):1011-1015.
作者姓名:谢海伟  陈仿军  朱斌  曹刚  金磊  周国志  吕进  曹秀峰
作者单位:南京医科大学附属南京医院肿瘤外科(南京市210006)
基金项目:本文课题受国家自然科学基金青年项目,南京市科委科技发展项目(编号201108027)资助This work was supported by the Young Scientist Funds of the National Natural Science Foundation of China,by the Nanjing City Committee of Science and Technology
摘    要:   目的  探讨长链非编码RNA SPRY4-IT1与食管鳞状细胞癌(ESCC)的临床病理及预后的相关性,以及对细胞生长的影响。   方法  收集2008年1月至2009年12月南京医科大学附属南京医院肿瘤外科50例ESCC手术切除标本(包括癌组织和癌旁组织),荧光实时定量PCR(qRT-PCR)检测50例ESCC中SPRY4-IT1的表达情况,分析其与临床病理及预后的关系,用小干扰RNA(siRNA)干扰SPRY4-IT1后MTT法检测其对细胞生长的影响,流式细胞检测对细胞凋亡和周期的影响。  结果  45例(90%)标本中SPRY4-IT1呈阳性表达,SPRY4-IT1在癌组织中的表达量显著高于癌旁组织(t=5.377,P < 0.01)。SPRY4-IT1的相对表达水平与肿瘤大小、临床分期相关(P均 < 0.05)。SPRY4-IT1在ESCC细胞株中表达量高于正常食管上皮细胞。KYSE30细胞中干扰SPRY4-IT1的表达后可明显减慢细胞生长,阻滞细胞周期并促进细胞凋亡(P < 0.01)。  结论   SPRY4-IT1在ESCC组织中显著高表达,并且能促进ESCC细胞生长,可能成为ESCC诊断和判断预后的重要分子标记物。 

关 键 词:食管鳞癌    长链非编码RNA    SPRY4-IT1    增殖    凋亡
收稿时间:2013-05-07

Long non-coding RNA SPRY4-IT1 expression in esophageal squamous cell carcinoma and its effects on cell growth
Haiwei XIE,Fangjun CHEN,Bin ZHU,Gang CAO,Lei JIN,Guozhi ZHOU,Jin LV,Xiufeng CAO.Long non-coding RNA SPRY4-IT1 expression in esophageal squamous cell carcinoma and its effects on cell growth[J].Chinese Journal of Clinical Oncology,2013,40(17):1011-1015.
Authors:Haiwei XIE  Fangjun CHEN  Bin ZHU  Gang CAO  Lei JIN  Guozhi ZHOU  Jin LV  Xiufeng CAO
Institution:Department of Surgical Oncology, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, China
Abstract:   Objective  This study aimed to clarify the correlation of SPRY4-IT1 expression with the clinicopathological characteristics and prognosis of patients with esophageal squamous cell carcinoma (ESCC), as well as the role of SPRY4-IT1 in promoting ESCC cell growth.   Methods  Quantitative real-time polymerase chain reaction for SPRY4-IT1 expression was performed on 50 paired cancerous and adjacent non-cancerous esophageal specimens. Small interfering RNA was used to suppress SPRY4-IT1 expression to further explore its role in tumor progression. Cell viability was tested in vitro by MTT assay (OD=490 nm), and cell apoptosis and cell cycle were investigated by flow cytometry.   Results  We found markedly elevated SPRY4-IT1 expression in cancerous tissues compared with adjacent non-cancerous tissues (90%, P < 0.01). Relative SPRY4-IT1 expression levels were correlated with some clinicopathological characteristics, such as tumor size (χ2=5.333, P=0.021), elevated TNM (2009) stage classi fication (χ2=5.556, P=0.018), and decreased overall survival rates (χ2=5.296, P=0.021). SPRY4-IT1 expression level was not correlated with patient age, gender, smoking status, or alcohol consumption (all P>0.05). Further experiments showed that SPRY4-IT1 expression levels were significantly higher in three ESCC cell lines than in the normal human esophageal epithelial cell line Het-1A. In vitro assays of the ESCC cell line KYSE30 demonstrated that knockdown of SPRY4-IT1 expression by small interfering RNA reduced cell growth, mediated cell cycle arrest at the G0-G1 phase, and promoted cell apoptosis (all P < 0.01).   Conclusion   SPRY4-IT1 was overexpressed in ESCC tissues and ESCC cell lines and promoted the growth of ESCC cells. The dysregulated expression of long non-coding RNA SPRY4-IT1 may play an important role in the process of ESCC development and may be developed as a useful biomarker for the diagnosis and prognosis of ESCC. 
Keywords:esophageal squamous cell carcinoma  long non-coding RNA  SPRY4-IT1  proliferation  apoptosis
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号